Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...

Market expert Sunil Subramaniam advised caution amid geopolitical uncertainty and rising input costs, while favouring consumer durables, ca...

Delhi is set to unveil a new city logistics plan aimed at boosting industrial investment. The national capital has achieved the highest 'Ex...

The gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath br...

Biocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...

Upwind, a US cloud security firm, is expanding into India and Asia-Pacific. Demand is rising from defense and government sectors due to cyb...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

OpenAI's Codex model is now available on Amazon Bedrock, a generative AI service from AWS. This integration allows businesses to leverage p...

The US-China AI rivalry has intensified, moving beyond innovation to a battle for talent, IP, and strategic tech. China's blocking of Meta'...

Devaansh Bhandari, a young tech enthusiast, landed a high-paying remote job with nearly ₹36 lakh annual salary. He bypassed traditional hir...

India is pursuing a multi-pronged approach to boost its exports to China. The nation is focusing on building its own industrial capabilitie...

Muse Spark AI model impact on Meta stock: Meta Platforms shares surged following the unveiling of its new AI model, Muse Spark. The company...

Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...

India's pharmaceutical industry is experiencing relief as active pharmaceutical ingredient (API) prices plummet due to overcapacity and agg...

India is trying to encourage local manufacture of APIs, intermediates and key starting material used in the production of drugs and cut dep...

The government is mulling incentives for reviving old pharmaceutical ingredient units.

Buy Aarti Drugs Ltd. at a price target of Rs 720.0 .